Edit search
Analysis of 3-year national reimbursement application data o…
Analysis of 3-year national reimbursement application data on etanercept and efalizumab for psoriasis.
Analysis of 3-year national reimbursement application data on etanercept and efalizumab for psoriasis.
Article, Chapter
Authors: R.J.B.
Publication: Volume:159, Page(s):760
Published: 2008
Browse related articles
  Request a copy of this item
Cite this item